文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

纤维蛋白原浓缩物与新鲜冰冻血浆对急性创伤性凝血病患者结局的影响:一项准实验研究

The effect of fibrinogen concentrate and fresh frozen plasma on the outcome of patients with acute traumatic coagulopathy: A quasi-experimental study.
PubMed 文献 · Am J Emerg Med · 2018-02-22
一句话结论严重钝性创伤(ISS>16)需输血患者中,纤维蛋白原组较新鲜冰冻血浆组和对照组死亡率、脓毒症、ICU入住需求、24小时输血输液量及住院时间均更低。

该准实验随机对照研究纳入90例严重钝性创伤(ISS>16)且需输注浓缩红细胞的患者,随机分为纤维蛋白原组、新鲜冰冻血浆(FFP)组和对照组,比较最终结局。纤维蛋白原组初始24小时所需浓缩红细胞(p=0.044)和静脉液体(p=0.022)显著更少,死亡率(p=0.029)、ICU入住需求(p=0.020)和住院时间(p=0.045)也更低。纤维蛋白原组和对照组脓毒症例数低于FFP组(p=0.001),纤维蛋白原组多器官衰竭例数约为其他两组的四分之一(p=0.106),需机械通气例数更少(p=0.191),三组均未检测到静脉血栓病例。

要点

  • 严重钝性创伤(ISS>16)需输浓缩红细胞的患者中,纤维蛋白原组初始24小时所需浓缩红细胞显著少于其他组(p=0.044),所需静脉液体也显著更少(p=0.022)。
  • 纤维蛋白原组死亡率(p=0.029)、ICU入住需求(p=0.020)和住院时间(p=0.045)均显著低于其他组。
  • 纤维蛋白原组和对照组脓毒症例数低于FFP组(p=0.001);纤维蛋白原组多器官衰竭例数约为其他两组的四分之一(p=0.106),需机械通气例数更少(p=0.191)。
  • 三组均未检测到静脉血栓病例。

适用人群与场景

  • 严重钝性创伤(ISS>16)且需输注浓缩红细胞的患者,平均年龄33.16±16.32岁,男性占82.2%。

诊断标准与关键阈值

  • 严重钝性创伤定义为损伤严重度评分(ISS)>16。

研究设计与关键结果

  • 准实验随机对照研究,纳入90例严重钝性创伤(ISS>16)需输浓缩红细胞的患者,随机分为纤维蛋白原组、新鲜冰冻血浆(FFP)组和对照组,三组基线特征相似。
  • 纤维蛋白原组初始24小时所需浓缩红细胞显著少于其他组(p=0.044),所需静脉液体也显著更少(p=0.022)。
  • 纤维蛋白原组死亡率(p=0.029)、ICU入住需求(p=0.020)和住院时间(p=0.045)均显著低于其他组。
  • 纤维蛋白原组和对照组脓毒症例数低于FFP组(p=0.001)。
  • 纤维蛋白原组多器官衰竭例数约为其他两组的四分之一(p=0.106),需机械通气例数更少(p=0.191)。
  • 三组均未检测到静脉血栓病例。

证据类型、等级与局限

  • 证据类型:准实验随机对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需输血的严重钝性创伤(ISS>16)患者在接受浓缩红细胞的同时给予纤维蛋白原,在死亡率、脓毒症、ICU入住需求、浓缩红细胞需求、初始24小时静脉液体需求及住院时间方面结局显著更好。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The debate on replacing coagulation factors and its effect on the final outcome of the patients with acute traumatic coagulopathy (ATC) in need of transfusion is still ongoing. Therefore, the present study is designed with the aim of comparing the outcome of patients with acute traumatic coagulopathies receiving fibrinogen and fresh frozen plasma (FFP).

METHODS: In this quasi-experimental randomized controlled study, patients with severe blunt trauma (ISS>16) and in need of packed cells transfusion were divided into 3 groups of receiving fibrinogen, receiving FFP, and control, and their final outcome was compared.

RESULTS: 90 patients with the mean age of 33.16±16.32years were randomly allocated to one of the 3 study groups (82.2% male). The 3 groups were similar regarding baseline characteristics. Patients receiving fibrinogen needed significantly less packed cells (p=0.044) and intravenous fluid in the initial 24h of hospitalization (p=0.022). In addition, mortality rate (p=0.029), need for admission to intensive care unit (p=0.020) and duration of hospitalization (p=0.045) were also lower in the group receiving fibrinogen. The number of sepsis cases in patients receiving fibrinogen and control group was lower than those who received FFP (p=0.001). The number of multiple organ failure cases in patients receiving fibrinogen was about one fourth of the other 2 groups (p=0.106), and a fewer number of them needed mechanical ventilation (p=0.191). No case of venous thrombosis was detected in any of the 3 groups.

CONCLUSION: Multiple trauma patients in need of transfusion who received fibrinogen along with packed cells had significantly better outcomes regarding mortality, sepsis, need for admission to the intensive care unit, need for receiving packed cells, need for receiving intravenous fluids in the initial 24h, and duration of hospitalization.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Akbari E, Safari S, Hatamabadi H, et al. The effect of fibrinogen concentrate and fresh frozen plasma on the outcome of patients with acute traumatic coagulopathy: A quasi-experimental study. Am J Emerg Med. 2018. PMID: 29502974. doi:10.1016/j.ajem.2018.02.018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。